Access cutting-edge ipf treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access ipf specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ipf treatment provided free
This is a randomized, double-blinded, placebo-controlled multicenter study to evaluate the safety and efficacy of DWN12088 in patients with Idiopathic Pulmonary Fibrosis.
Sponsor: Daewoong Pharmaceutical Co. LTD.
Check if you qualify for this ipf clinical trial in Kansas City, KS
If you're searching for ipf treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ipf specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.